Additional file 2 of Ruxolitinib-corticosteroid as first-line therapy for newly diagnosed high-risk acute graft versus host disease: study protocol for a multicenter, randomized, phase II controlled trial

Additional file 2: Supplementary Table 1. Study procedure and Flow Chart (treatment phase prior to end of study).